Full-Time
Histotechnologist 2
Posted on 5/16/2026
Exact Sciences
5,001-10,000 employees
Develops cancer screening and diagnostic tests
Compensation Overview
$56k - $100k/yr
No H1B Sponsorship
Phoenix, AZ, USA
In Person
Bachelor's, Associate's
 Biology & Biotech (1) |
|---|
Get referred to Exact Sciences
See people who can refer or advise you
- Successful completion of a NAACLS accredited Histotechnician program, 3+ years of laboratory experience (one year of experience can be counted from the program completion).
- Or High School diploma, 5+ years of laboratory experience.
- Or Associate Degree in a scientific field, 3+ years of laboratory experience.
- Or Bachelor Degree in a scientific field, 1+ years of laboratory experience.
- Basic computer skills to include internet navigation and email usage.
- Demonstrated ability to perform the essential duties of the position with or without accommodation.
- Authorization to work in the United States without sponsorship.
- Label documentation of formalin-fixed paraffin-embedded (FFPE) blocks, slides, and microcentrifuge tubes by following standard operating procedures (SOPs).
- Routine sectioning, fixation, and processing procedures related to hematoxylin and eosin (H&E) staining/slide production for fresh frozen (FF) and FFPE samples according to SOPs.
- Prepare and perform processing procedures for DNA and RNA analyze extraction according to SOPs.
- Label accessioned samples/sample containers and test requisition form using the laboratory labeling system with assigned number specific to the patient case from laboratory information system (LIS) accessioning.
- Prepare and perform all aspects related to the routine processing of FF tissue samples, to include preparation for tumor estimate procedure, according to SOPs.
- Accession and enter data of received patient samples and specific test request into LIS according to SOPs.
- File and store all slides and FFPE tissue blocks.
- Assist with the initial quality review of incoming specimens.
- Maintain all histology equipment and corresponding documentation; including, but not limited to, quality control worksheets, preventive maintenance records, and day-to-day maintenance.
- Enter data into the histology portion of the information management system (IMS).
- Perform routine and/or non-routine histology procedures, and regularly review work to ensure work is carried out in accordance with established policies and procedures.
- Perform microdissection of unstained slides in accordance with markings of stained slides provided.
- Prepare reagents, solutions, and controls.
- Perform and document equipment maintenance and calibration.
- Assist in sample returns, as needed.
- Interact with pathologists and laboratory staff, in accordance with SOPs, to ensure specimens are processed in a timely manner with high quality.
- Provide materials and reagent receipt and management in accordance with SOPs.
- Provide technical assistance to other staff, as needed.
- Assist in training team members, as needed.
- Perform H&E staining.
- Monitor and process the histology queue for various tasks that need to be performed and perform these tasks with minimal supervision.
- Ability to prioritize and drive to results with a high emphasis on quality.
- Ability to work independently as well as part of a team.
- Ability to multi-task and rapidly switch directions to accommodate changes in study designs.
- Display high attention to detail.
- Strong interpersonal and written and verbal communication skills.
- Uphold company mission and values through accountability, innovation, integrity, quality, and teamwork.
- Support and comply with the company’s Quality Management System policies and procedures.
- Maintain regular and reliable attendance.
- Ability to act with an inclusion mindset and model these behaviors for the organization.
- Ability to work designated schedule.
- Ability to work nights and/or weekends, as needed.
- Ability to work overtime, as needed.
- Ability to use various types of laboratory equipment; including microscopes, microtomes, blades, strainers, and pipettes for extended periods of time.
- May perform repetitious actions using lab tools.
- Ability to use near vision to view samples at close range.
- Ability to spend considerable periods of time concentrating, reading, or analyzing data, or applying scientific rules.
- May be exposed to hazardous materials, tissue specimens, and instruments with moving parts, lasers, heating and freezing elements, and high-speed centrifugation.
- Ability to grasp with both hands; pinch with thumb and forefinger; turn with hand/arm; reach above shoulder height.
- Ability to comply with any applicable personal protective equipment requirements.
- Possession of active ASCP Board of Certification, such as HT ASCP, HLT ASCP.
Exact Sciences develops and sells cancer screening and diagnostic tests that aim to detect cancer at its earliest stages and inform treatment decisions. The tests are designed to analyze biological samples to identify cancer signals, enabling healthcare providers to screen patients, diagnose cancer earlier, and tailor therapies accordingly. The company differentiates itself through its global reach, collaborations with healthcare organizations, and a business model that centers on test sales and partnerships, not just standalone products. Its goal is to reduce the burden of cancer by improving early detection, enabling timely interventions, and supporting patients and clinicians with diagnostic information.
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
Madison, Wisconsin
Founded
1995
Get referred to Exact Sciences
See people who can refer or advise you
Simplify's Take
What believers are saying
- Abbott closed the $23 billion Exact deal on March 23, 2026, validating strategic value.
- February 2026 Medicare pathway legislation strengthened Exact's MCED reimbursement prospects for Cancerguard.
- March 2026 TNBC data broadened Oncodetect evidence and support recurrence-risk clinical adoption.
What critics are saying
- July 2026 ShinyHunters leak exposed 10.9 million records, triggering class-action litigation.
- Abbott must integrate Exact after the March 23, 2026 acquisition while absorbing $0.20 EPS dilution.
- Cancerguard remains unapproved by FDA, and weak clinical adoption would cripple the growth story.
What makes Exact Sciences unique
- Cologuard anchors Exact's at-home colorectal screening franchise, scaled through Abbott's diagnostics platform.
- Oncotype DX guides breast cancer treatment decisions with entrenched clinician adoption.
- Oncodetect and Cancerguard extend Exact from screening into recurrence monitoring and multi-cancer detection.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Paid Vacation
Parental Leave
401(k) Retirement Plan
Wellness Program
Stock Options
Growth & Insights and Company News
6 month growth
↓ -3%1 year growth
↑ 1%2 year growth
↑ 1%Exact Sciences - 10,869,543 breached accounts. August 7, 2026 In July 2026, Exact Sciences (now owned by Abbott Laboratories) was the target of a ShinyHunters "pay or leak" extortion campaign. The group claimed to have obtained data from the company's cancer diagnostics business, which they later published publicly. The breach contained 10.9M unique email addresses belonging to customers, patients and healthcare providers, along with names, addresses, phone numbers and health records. Abbott subsequently published a public notice advising that "some of the impacted files contain personal information and/or personal health information" and that more specific information would follow once their review of the incident was complete. For context, Exact Sciences is the maker of the Cologuard at-home colorectal cancer screening test.
Patient sues Abbott Labs, Exact Sciences in Data Theft. Class Action Suit Claims Labs Failed to Safeguard Data in ShinyHunters Hack Marianne Kolbasuk McGee (HealthInfoSec) - July 24, 2026 The first of what could be many more proposed class action lawsuits has been filed in a U.S. federal court against clinical testing laboratory and medical device maker Abbott Laboratories and its cancer diagnostics business Exact Sciences in the wake of a data theft hack claimed last week by notorious cybercrime gang ShinyHunters. The lawsuit filed in an Illinois federal court alleges, among other claims, that the Illinois-based Abbott and its Exact Sciences business - which provides cancer screenings, diagnostic testing, and related laboratory services to patients and healthcare providers in the United States - failed to implement "necessary data security safeguards" to protect the plaintiff's and class members' sensitive personal and health information from unauthorized access and theft by cybercriminals. "The data breach and the injuries it caused to plaintiff and class members occurred as direct, proximate and foreseeable results of multiple failings on the part of defendants," alleges the lawsuit filed on Wednesday by Brian Troesch - a patient of Exact Sciences, on behalf of himself and other individuals similar situated. "This failure resulted in cybercriminals accessing the private information of defendants' current and former patients." The lawsuit is seeking monetary damages as well as injunctive relief requiring Abbott and Exact Sciences to strengthen their data security systems and monitoring procedures and conduct periodic audits of those IT systems. In addition, the lawsuit wants Abbott to provide "lifetime credit monitoring and identity theft insurance to plaintiff and class members." Abbott Labs in a July 16 statement posted on its website acknowledged it's investigating a breach involving its Exact Sciences business. Abbott said the incident appears to involve unauthorized access to a limited number of internal systems in the company's Cancer Diagnostics business only (see: Craneware, Abbott Probe Separate Health Data Theft Incidents). "This does not impact any business operations, product or product availability, manufacturing or lab operations, or our ability to serve patients," the company said. "There is no impact to any other Abbott businesses, sites or systems. The legacy Exact Sciences systems are separate from Abbott's." But the Exact Sciences incident is not the only alleged hack Abbott confirmed it's investigating. The company in a statement to ISMG on Monday acknowledged that the company is also investigating claims that another threat actor gained access to Abbott's LabCentral portal. Cybercrime gang ShadowByt3$ claimed to media outlet Bleeping Computer this week to have exfiltrated an array of manufacturing certificates, operation manuals, technical specifications, regulatory documentation, product requirement archives, calibrator value assignments, assay files and other product documentation related to Abbott's laboratory diagnostic systems. ShinyHunters on its dark website on Friday still listed "Abbott-owned Exact Sciences" as a victim, indicating that it had extended until July 21 its threat for the company to "pay or leak." "We have made an extension to your deadline. We are issuing one last final warning due to the severity of this case. You wouldn't want us to describe what was exfiltrated from you publicly," ShinyHunters wrote. As of Friday, which was three days after that supposed final deadline, ShinyHunters had appeared to not yet begin leaking Abbott's data. Abbott on Friday declined further comment to ISMG on either cyber incident, ShinyHunter's latest threats or the proposed class action lawsuit filed by Troesch.
Abbott Laboratories data breach: what current and former employees need to know. July 23, 2026 NOTICE: If you received a NOTICE OF DATA BREACH letter from Abbott Laboratories, contact Emery | Reddy, PC at 206.207.8929 for a Free Case Review. On July 16, 2026, Abbott Laboratories publicly confirmed that it is investigating unauthorized access to legacy computer systems belonging to Exact Sciences, the cancer-diagnostics company behind Cologuard and other at-home cancer screening tests, which Abbott acquired in late 2025. Abbott says the intrusion traces back to a vishing (voice phishing) attack against Abbott and Exact Sciences employees in mid-June 2026, which allowed attackers to compromise a Microsoft Entra single sign-on account and gain access to internal systems. A cybercriminal group calling itself ShinyHunters has claimed responsibility and told the security news outlet BleepingComputer that it exfiltrated approximately 30 million rows of customer data, including roughly 1 million Social Security numbers, along with names, contact information, and dates of birth, from the legacy Exact Sciences systems. Abbott has not confirmed these figures. The company has acknowledged unauthorized access to the legacy systems but has not yet disclosed the scope or volume of data involved, and has stated it does not expect a material impact on its business or financial results. Why this matters. Abbott reportedly engaged with ShinyHunters, and the group's leak deadline was extended to July 21, 2026. As of the most recent reporting, the claimed data had not yet been published, but that could change at any time, and Abbott has not said whether a payment was made to the attackers. This breach originated from a vishing attack that specifically targeted Abbott and Exact Sciences employees, tricking staff into giving up credentials that opened the door to internal systems. Because no official breach notification has been sent to individuals and no state regulatory filing has been made yet, Emery | Reddy is currently focused on hearing from current and former Abbott and Exact Sciences employees who believe they may have been affected, whether through the compromised credentials themselves or the broader systems those credentials exposed. A separate, apparently unrelated claim from a second group (ShadowByt3$) involves Abbott's LabCentral customer portal. Abbott says that portal holds only non-sensitive public reference materials, and we are not treating it as part of this incident. According to the claims made by the ShinyHunters group, not yet confirmed by Abbott, the exposed data may include: * Full name * Contact information * Full date of birth * Social Security number (claimed for approximately 1 million individuals) Treat these figures as an unconfirmed threat-actor claim pending Abbott's own accounting of the incident. What is Abbott offering affected individuals? This is a pre-notice case: no official breach notification has been sent to individuals, and no state regulatory filing has been made as of this writing. Abbott has not yet announced credit monitoring, identity theft protection, or any other remedy. We will update this post as soon as Abbott issues formal notice. Your information is at risk. If the claimed data set holds up, the combination of full name, date of birth, and Social Security number is exactly the kind of information used to open fraudulent accounts and commit identity theft. Affected individuals, including current and former employees whose credentials may have been targeted, should: * Watch for phishing, vishing, or unusual communications referencing Abbott or Exact Sciences * If you believe your own login credentials may have been part of the compromised SSO access, reset your passwords and enable multi-factor authentication * Monitor your credit reports and consider a fraud alert or credit freeze * Save any communication you receive from Abbott about this incident * Contact Emery | Reddy for a Free Case Review even before a formal notice is issued Companies that collect and store sensitive personal information, including employee credentials and customer records, have a legal obligation to safeguard it. When that obligation is not met, affected individuals may have legal rights and remedies worth discussing with an attorney. Your Personally Identifiable Information (PII) includes information that can be used to identify you, such as your name and other personal details. Organizations that manage healthcare data are legally required to safeguard this information. When PII is exposed in a data breach, it can potentially be used by cybercriminals to commit identity theft, financial fraud, or other misuse. Much of the information involved in this incident may also qualify as Protected Health Information (PHI). PHI includes medical or healthcare-related data protected under federal and state privacy laws. When PHI is compromised, it can be misused for medical identity theft or insurance fraud. Residents of California may be entitled to additional protections under the California Consumer Privacy Act (CCPA), which provides enhanced rights regarding the collection, use, and safeguarding of personal information. Faq. How many people were affected by the Abbott Laboratories data breach? Not confirmed by Abbott. The threat actor ShinyHunters claims approximately 1 million Social Security numbers among 30 million rows of exfiltrated data; treat this as an unconfirmed claim pending Abbott's own accounting. What information was exposed? Per the attacker's claims (not yet Abbott-confirmed): full name, contact information, date of birth, and Social Security number for a subset of individuals. Has Abbott sent notice letters? Not yet. Abbott publicly confirmed the incident on July 16, 2026, but has not issued individual notification letters or a state regulatory filing as of this writing; this is a pre-notice case. Why is Emery | Reddy reaching out to employees specifically? The breach originated from a vishing attack targeting Abbott and Exact Sciences employee credentials. Since formal notice to the broader customer base hasn't gone out yet, we're currently gathering information from current and former employees who believe they may have been affected. What should I do if I'm a current or former Abbott or Exact Sciences employee? Contact us for a free case review, and if you believe your own credentials may have been part of the compromised SSO access, reset your passwords and enable multi-factor authentication. Join the data breach lawsuit. 0 of 200 max characters Max. file size: 256 MB. Prefer to speak with someone now? Call us at (206) 973-5298 for a Free Case Review. We fight for you Meet the team. Whether you've been injured on the job, subjected to mistreatment in the workplace, or affected by a privacy breach, our expert attorneys are here to help.
PRIVACY ALERT: Abbott Laboratories and Exact Sciences Corporation under investigation for data breach of patient records. Classactionlawyers is investigating a data breach that led to unauthorized access to the sensitive information of patients affiliated with Abbott Laboratories ("Abbott"), an Illinois-based healthcare and medical device company, and its subsidiary Exact Sciences Corporation, a Wisconsin-based company specializing in cancer screening and precision oncology diagnostics. In July 2026, an unauthorized third party accessed legacy cancer diagnostics systems of Exact Sciences. The cybercriminal group ShinyHunters claimed responsibility for the data breach and allegedly exfiltrated names, contact information, dates of birth, and one million Social Security numbers. Abbott and Exact Sciences have not confirmed whether the above listed data or other sensitive data was exfiltrated. Abbott and Exact Sciences also have not begun notifying affected individuals yet, which may have violated state and federal laws. If your personal information was impacted by this incident, you may be at risk of identity theft and other serious violations of your privacy. As a result, you may be entitled to money damages and an injunction requiring changes to Abbott's and Exact Sciences' cybersecurity practices. If you received notification of this data breach or are affiliated with Abbott or Exact Sciences, and wish to obtain additional information about your legal rights, please fill out the from below.
Ransomware Group shinyhunters hits: Abbott owned Exact Sciences Corporation. HookPhish team Summary. In the latest cybersecurity news, Abbott owned Exact Sciences Corporation - an organization based in US - has fallen victim to a ransomware attack conducted by the group shinyhunters. This data breach, discovered on Jul 15, 2026, 00:00 UTC, underscores the increasing need for proactive cybersecurity defenses as Hookphish continue through 2026. Incident report. | Target Organization | Abbott owned Exact Sciences Corporation | | Threat Group | shinyhunters | | Summary | You wouldn't want Hookphish to describe what was exfiltrated from you publicly. This is a final warning to reach out by 18 July 2026 before Hookphish leak along with several annoying (digital) problems that'll come your way. Make the right decision, don't be the next headline. Updated: 15 July 2026 | Warning: FINAL WARNING PAY OR LEAK | | Date of Breach | Jul 15, 2026, 00:00 UTC | | Discovery Date | Jul 15, 2026, 00:00 UTC | | Region | US | | Business Sector | Healthcare | How to reduce your ransomware risk. Most ransomware intrusions start with a stolen password or a phishing email. A few proactive steps sharply cut your exposure: * security awareness training - close the gap attackers exploit. * dark web monitoring - close the gap attackers exploit. Disclaimer. HookPhish does not engage in the exfiltration, downloading, taking, hosting, viewing, reposting, or disclosure of any stolen information. All breach data reported here is sourced from publicly available threat intelligence feeds for awareness purposes only.